Selenoproteins and selenium status in bone physiology and pathology

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 11, 2014, Pages 3246-3256

  Zhang, Zhichao ^a   Zhang, Jinsong ^b   Xiao, Jianru ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b ANHUI AGRICULTURAL UNIVERSITY   (China)

Author keywords

Bone; Osteoblast; Osteoclast; Selenium; Selenoprotein

Indexed keywords

AROMATASE INHIBITOR; AURANOFIN; AUROTHIOGLUCOSE; CURCUMIN; DIHYDROXYCOLECALCIFEROL; ESTROGEN; GLUTATHIONE PEROXIDASE; GOLD DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOPONTIN; SELENIUM; SELENOCYSTEINE; SELENOPROTEIN; SELENOPROTEIN P; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 1; TRANSCRIPTION FACTOR RUNX2; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ANASTROZOLE; CALCITRIOL; NANOPARTICLE; SELENIUM NANOPARTICLE; THIOREDOXIN; UNCLASSIFIED DRUG; VITAMIN D;

ANTIOXIDANT ACTIVITY; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASE; BREAST CARCINOMA; BREAST METASTASIS; DIET SUPPLEMENTATION; DRUG POTENCY; DRUG TARGETING; ENZYME ACTIVITY; FRAGILITY FRACTURE; GENE INACTIVATION; GPX1 GENE; HOMEOSTASIS; HUMAN; KASHIN BECK DISEASE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; RHEUMATOID ARTHRITIS; RISK REDUCTION; SELENIUM DEFICIENCY; SEPP GENE; TRXR1 GENE; BONE MASS; BONE MATURATION; BONE METASTASIS; BREAST CANCER; GROWTH RETARDATION; HIP FRACTURE; OSTEOPOROSIS; POSTMENOPAUSE; SELENIUM BLOOD LEVEL; TRABECULAR BONE;

EID: 84906713658     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.08.001     Document Type: Review

References (209)

1. Z.R. Stoytcheva, and M.J. Berry Transcriptional regulation of mammalian selenoprotein expression Biochim. Biophys. Acta 1790 2009 1429 1440
2. M.A. Reeves, and P.R. Hoffmann The human selenoproteome: recent insights into functions and regulation Cell. Mol. Life Sci. 66 2009 2457 2478
3. J. Lu, and A. Holmgren Selenoproteins J. Biol. Chem. 284 2009 723 727
4. S. Gromer, J.K. Eubel, B.L. Lee, and J. Jacob Human selenoproteins at a glance Cell. Mol. Life Sci. 62 2005 2414 2437 (Pubitemid 41801097)
5. J. Donovan, and P.R. Copeland Threading the needle: getting selenocysteine into proteins Antioxid. Redox Signal. 12 2010 881 892
6. D.L. Hatfield, B.A. Carlson, X.M. Xu, H. Mix, and V.N. Gladyshev Selenocysteine incorporation machinery and the role of selenoproteins in development and health Prog. Nucleic Acid Res. Mol. Biol. 81 2006 97 142 (Pubitemid 44767504)
7. E.S. Arnér Selenoproteins - what unique properties can arise with selenocysteine in place of cysteine? Exp. Cell Res. 316 2010 1296 1303
8. R.J. Hondal, and E.L. Ruggles Differing views of the role of selenium in thioredoxin reductase Amino Acids 41 2011 73 89
9. G.W. Snider, E. Ruggles, N. Khan, and R.J. Hondal Selenocysteine confers resistance to inactivation by oxidation in thioredoxin reductase: comparison of selenium and sulfur enzymes Biochemistry 52 2013 5472 5481
10. R. Koishi, T. Nakamura, T. Takazawa, C. Yoshimura, and N. Serizawa Production of functional human selenocysteine-containing KDRF/thioredoxin reductase in E. Coli J. Biochem. 127 2000 977 983 (Pubitemid 30430151)
11. S. Bar-Noy, S.N. Gorlatov, and T.C. Stadtman Overexpression of wild type and SeCys/Cys mutant of human thioredoxin reductase in E. Coli: the role of selenocysteine in the catalytic activity Free Radic. Biol. Med. 30 2001 51 61 (Pubitemid 32008088)
12. L. Schomburg, U. Schweizer, and J. Köhrle Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic Cell. Mol. Life Sci. 61 2004 1988 1995 (Pubitemid 39149889)
13. J.R. Arthur The glutathione peroxidases Cell. Mol. Life Sci. 57 2000 1825 1835 (Pubitemid 32102578)
14. R. Brigelius-Floh Tissue-specific functions of individual glutathione peroxidases Free Radic. Biol. Med. 27 1999 951 965
15. R. Brigelius-Flohé Glutathione peroxidases and redox-regulated transcription factors Biol. Chem. 387 2006 1329 1335 (Pubitemid 44691411)
16. X.G. Lei Glutathione peroxidase-1 gene knockout on body antioxidant defense in mice Biofactors 14 2001 93 99
17. E.S. Arnér Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions Biochim. Biophys. Acta 1790 2009 495 526
18. A. Holmgren Antioxidant function of thioredoxin and glutaredoxin systems Antioxid. Redox Signal. 2 2000 811 820 (Pubitemid 32062330)
19. E.S. Arnér, and A. Holmgren Physiological functions of thioredoxin and thioredoxin reductase Eur. J. Biochem. 267 2000 6102 6109
20. A.K. Rundlöf, and E.S. Arnér Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events Antioxid. Redox Signal. 6 2004 41 52 (Pubitemid 38063974)
21. J. Nordberg, and E.S. Arnér Reactive oxygen species, antioxidants, and the mammalian thioredoxin system Free Radic. Biol. Med. 31 2001 1287 1312 (Pubitemid 33145299)
22. J. Lu, and A. Holmgren Thioredoxin system in cell death progression Antioxid. Redox Signal. 17 2012 1738 1747
23. M.V. Kasaikina, D.L. Hatfield, and V.N. Gladyshev Understanding selenoprotein function and regulation through the use of rodent models Biochim. Biophys. Acta 1823 2012 1633 1642
24. C.B. Allan, G.M. Lacourciere, and T.C. Stadtman Responsiveness of selenoproteins to dietary selenium Annu. Rev. Nutr. 19 1999 1 16 (Pubitemid 29380594)
25. K.M. Brown, and J.R. Arthur Selenium, selenoproteins and human health: a review Public Health Nutr. 4 2001 593 599 (Pubitemid 32524579)
26. H. Zeng, J.J. Cao, and G.F. Combs Jr. Selenium in bone health: roles in antioxidant protection and cell proliferation Nutrients 5 2013 97 110
27. J.M. Park, A. Kim, J.H. Oh, and A.S. Chung Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation Carcinogenesis 28 2007 837 847 (Pubitemid 46530375)
28. M.J. Christensen, E.T. Nartey, A.L. Hada, R.L. Legg, and B.R. Barzee High selenium reduces NF-kappaB-regulated gene expression in uninduced human prostate cancer cells Nutr. Cancer 58 2007 197 204 (Pubitemid 47328771)
29. S. Jüliger, H. Goenaga-Infante, T.A. Lister, J. Fitzgibbon, and S.P. Joel Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species Cancer Res. 67 2007 10984 10992 (Pubitemid 350145928)
30. N.Y. Alwahaibi, S.B. Budin, J. Mohamed, and A. Alhamdani Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis J. Gastroenterol. Hepatol. 25 2010 786 791
31. F. Zhang, W. Yu, J.L. Hargrove, P. Greenspan, R.G. Dean, E.W. Taylor, and D.K. Hartle Inhibition of TNF-alpha induced ICAM-1, VCAM-1 and E-selectin expression by selenium Atherosclerosis 161 2002 381 386 (Pubitemid 34219191)
32. D.W. Jeong, M.H. Yoo, T.S. Kim, J.H. Kim, and I.Y. Kim Protection of mice from allergen-induced asthma by selenite: prevention of eosinophil infiltration by inhibition of NF-kappa B activation J. Biol. Chem. 277 2002 17871 17876 (Pubitemid 34967596)
33. K.S. Prabhu, F. Zamamiri-Davis, J.B. Stewart, J.T. Thompson, L.M. Sordillo, and C.C. Reddy Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kappaB in up-regulation Biochem. J. 366 2002 203 209 (Pubitemid 34971819)
34. F. Zamamiri-Davis, Y. Lu, J.T. Thompson, K.S. Prabhu, P.V. Reddy, L.M. Sordillo, and C.C. Reddy Nuclear factor-kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency Free Radic. Biol. Med. 32 2002 890 897 (Pubitemid 34439259)
35. J.L. Fischer, E.M. Mihelc, K.E. Pollok, and M.L. Smith Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair Mol. Cancer Ther. 6 2007 355 361 (Pubitemid 46206700)
36. Y.R. Seo, M.R. Kelley, and M.L. Smith Selenomethionine regulation of p53 by a ref1-dependent redox mechanism Proc. Natl. Acad. Sci. U. S. A. 99 2002 14548 14553 (Pubitemid 35257708)
37. S.W. Jeong, H.J. Jung, M.M. Rahman, J.N. Hwang, and Y.R. Seo Protective effects of selenomethionine against ionizing radiation under the modulation of p53 tumor suppressor J. Med. Food 12 2009 389 393
38. J.L. Fischer, J.K. Lancia, A. Mathur, and M.L. Smith Selenium protection from DNA damage involves a Ref1/p53/Brca1 protein complex Anticancer Res. 26 2006 899 904
39. W.M. El-Sayed, T. Aboul-Fadl, J.G. Lamb, J.C. Roberts, and M.R. Franklin Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice Toxicology 220 2006 179 188 (Pubitemid 43276407)
40. H. Xiao, and K.L. Parkin Induction of phase II enzyme activity by various selenium compounds Nutr. Cancer 55 2006 210 223 (Pubitemid 44719636)
41. D. Wang, E.W. Taylor, Y. Wang, X. Wan, and J. Zhang Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention Int. J. Nanomedicine 7 2012 1711 1721
42. C. Ip, H.J. Thompson, Z. Zhu, and H.E. Ganther In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention Cancer Res. 60 2000 2882 2886 (Pubitemid 30395810)
43. G.X. Li, H.J. Lee, Z. Wang, H. Hu, J.D. Liao, J.C. Watts, G.F. Combs Jr., and J. Lü Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite Carcinogenesis 29 2008 1005 1012 (Pubitemid 351982246)
44. Z. Wang, C. Jiang, and J. Lü Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol Mol. Carcinog. 34 2002 113 120 (Pubitemid 34747321)
45. R. Irons, B.A. Carlson, D.L. Hatfield, and C.D. Davis Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression J. Nutr. 136 2006 1311 1317
46. H.E. Ganther Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase Carcinogenesis 20 1999 1657 1666 (Pubitemid 29410542)
47. A. Ghose, J. Fleming, K. El-Bayoumy, and P.R. Harrison Enhanced sensitivity of human oral carcinomas to induction of apoptosis by selenium compounds: involvement of mitogen-activated protein kinase and Fas pathways Cancer Res. 61 2001 7479 7487 (Pubitemid 32995037)
48. G.F. Combs Jr., L.C. Clark, and B.W. Turnbull An analysis of cancer prevention by selenium Biofactors 14 2001 153 159 (Pubitemid 32848310)
49. W.J. Boyle, W.S. Simonet, and D.L. Lacey Osteoclast differentiation and activation Nature 423 2003 337 342 (Pubitemid 40852708)
50. K. Matsuo, and N. Irie Osteoclast-osteoblast communication Arch. Biochem. Biophys. 473 2008 201 209
51. N.A. Sims, and J.H. Gooi Bone remodeling: multiple cellular interactions required for coupling of bone formation and resorption Semin. Cell Dev. Biol. 19 2008 444 451
52. K. Nakahama Cellular communications in bone homeostasis and repair Cell. Mol. Life Sci. 67 2010 4001 4009
53. T. Suda, N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families Endocr. Rev. 20 1999 345 357 (Pubitemid 30649812)
54. S.C. Manolagas From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis Endocr. Rev. 31 2010 266 300
55. F. Wauquier, L. Leotoing, V. Coxam, J. Guicheux, and Y. Wittrant Oxidative stress in bone remodelling and disease Trends Mol. Med. 15 2009 468 477
56. X.C. Bai, D. Lu, A.L. Liu, Z.M. Zhang, X.M. Li, Z.P. Zou, W.S. Zeng, B.L. Cheng, and S.Q. Luo Reactive oxygen species stimulates receptor activator of NF-kappaB ligand expression in osteoblast J. Biol. Chem. 280 2005 17497 17506 (Pubitemid 41389222)
57. N.K. Lee, Y.G. Choi, J.Y. Baik, S.Y. Han, D.W. Jeong, Y.S. Bae, N. Kim, and S.Y. Lee A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation Blood 106 2005 852 859 (Pubitemid 41076424)
58. J.M. Lean, C.J. Jagger, B. Kirstein, K. Fuller, and T.J. Chambers Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation Endocrinology 146 2005 728 735 (Pubitemid 40129828)
59. I. Dreher, N. Schütze, A. Baur, K. Hesse, D. Schneider, J. Köhrle, and F. Jakob Selenoproteins are expressed in fetal human osteoblast-like cells Biochem. Biophys. Res. Commun. 245 1998 101 107 (Pubitemid 28414254)
60. R. Ebert, M. Ulmer, S. Zeck, J. Meissner-Weigl, D. Schneider, H. Stopper, N. Schupp, M. Kassem, and F. Jakob Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro Stem Cells 24 2006 1226 1235 (Pubitemid 44464691)
61. N. Pietschmann, E. Rijntjes, A. Hoeg, M. Stoedter, U. Schweizer, P. Seemann, and L. Schomburg Selenoprotein P is the essential selenium transporter for bones Metallomics 6 2014 1043 1049
62. M. Leist, B. Raab, S. Maurer, U. Rösick, and R. Brigelius- Flohé Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity Free Radic. Biol. Med. 21 1999 297 306 (Pubitemid 26271719)
63. F. Jakob, K. Becker, E. Paar, R. Ebert-Duemig, and N. Schütze Expression and regulation of thioredoxin reductases and other selenoproteins in bone Methods Enzymol. 347 2002 168 179 (Pubitemid 34233270)
64. H. Liu, W. Bian, S. Liu, and K. Huang Selenium protects bone marrow stromal cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation by suppressing oxidative stress and ERK signaling pathway Biol. Trace Elem. Res. 150 2012 441 450
65. A.K. Rundlöf, M. Carlsten, and E.S. Arnér The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene J. Biol. Chem. 276 2001 30542 30551
66. K.J. Hintze, K.A. Wald, H. Zeng, E.H. Jeffery, and J.W. Finley Thioredoxin reductase in human hepatoma cells is transcriptionally regulated by sulforaphane and other electrophiles via an antioxidant response element J. Nutr. 133 2003 2721 2727 (Pubitemid 37099751)
67. J. Zhang, V. Svehlíková, Y. Bao, A.F. Howie, G.J. Beckett, and G. Williamson Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation Carcinogenesis 24 2003 497 503 (Pubitemid 36432646)
68. L.N. Barrera, A. Cassidy, W. Wang, T. Wei, N.J. Belshaw, I.T. Johnson, R. Brigelius-Flohé, and Y. Bao TrxR1 and GPx2 are potently induced by isothiocyanates and selenium, and mutually cooperate to protect Caco-2 cells against free radical-mediated cell death Biochim. Biophys. Acta 1823 2012 1914 1924
69. W. Wang, S. Wang, A.F. Howie, G.J. Beckett, R. Mithen, and Y. Bao Sulforaphane, erucin, and iberin up-regulate thioredoxin reductase 1 expression in human MCF-7 cells J. Agric. Food Chem. 53 2005 1417 1421 (Pubitemid 40322128)
70. L. Campbell, F. Howie, J.R. Arthur, F. Nicol, and G. Beckett Selenium and sulforaphane modify the expression of selenoenzymes in the human endothelial cell line EAhy926 and protect cells from oxidative damage Nutrition 23 2007 138 144 (Pubitemid 46096722)
71. A. Gurlek, M.R. Pittelkow, and R. Kumar Modulation of growth factor/cytokine synthesis and signaling by 1alpha,25-dihydroxyvitamin D(3): implications in cell growth and differentiation Endocr. Rev. 23 2002 763 786 (Pubitemid 35454588)
72. N. Schütze, J. Fritsche, R. Ebert-Dümig, D. Schneider, J. Köhrle, R. Andreesen, M. Kreutz, and F. Jakob The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells - regulation by 1,25-dihydroxyvitamin D3 and selenite Biofactors 10 1999 329 338
73. N. Schütze, M. Bachthaler, A. Lechner, J. Köhrle, and F. Jakob Identification by differential display PCR of the selenoprotein thioredoxin reductase as a 1 alpha,25(OH)2-vitamin D3-responsive gene in human osteoblasts - regulation by selenite Biofactors 7 1998 299 310 (Pubitemid 28305023)
74. G. Shaw, and R. Kamen A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation Cell 46 1986 659 667
75. J. Lean, B. Kirstein, Z. Urry, T. Chambers, and K. Fuller Thioredoxin-1 mediates osteoclast stimulation by reactive oxygen species Biochem. Biophys. Res. Commun. 321 2004 845 850 (Pubitemid 39044387)
76. B.K. Sarma, and G. Mugesh Glutathione peroxidase (GPx)-like antioxidant activity of the organoselenium drug ebselen: unexpected complications with thiol exchange reactions J. Am. Chem. Soc. 127 2005 11477 11485 (Pubitemid 41176909)
77. C.S. Hoefig, K. Renko, J. Köhrle, M. Birringer, and L. Schomburg Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture J. Nutr. Biochem. 22 2011 945 955
78. C.J. Aitken, J.M. Hodge, Y. Nishinaka, T. Vaughan, J. Yodoi, C.J. Day, N.A. Morrison, and G.C. Nicholson Regulation of human osteoclast differentiation by thioredoxin binding protein-2 and redox-sensitive signaling J. Bone Miner. Res. 19 2004 2057 2064 (Pubitemid 41103421)
79. H. Takayanagi, S. Kim, K. Matsuo, H. Suzuki, T. Suzuki, K. Sato, T. Yokochi, H. Oda, K. Nakamura, N. Ida, E.F. Wagner, and T. Taniguchi RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta Nature 416 2002 744 749 (Pubitemid 34429151)
80. M.E. Budiman, J.L. Bubenik, A.C. Miniard, L.M. Middleton, C.A. Gerber, A. Cash, and D.M. Driscoll Eukaryotic initiation factor 4a3 is a selenium-regulated RNA-binding protein that selectively inhibits selenocysteine incorporation Mol. Cell 35 2009 479 489
81. J.E. Squires, I. Stoytchev, E.P. Forry, and M.J. Berry SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay Mol. Cell. Biol. 27 2007 7848 7855 (Pubitemid 350086418)
82. S.C. Low, E. Grundner-Culemann, J.W. Harney, and M.J. Berry SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy EMBO J. 19 2000 6882 6890 (Pubitemid 32011681)
83. J.C. McCann, and B.N. Ames Adaptive dysfunction of selenoproteins from the perspective of the triage theory: why modest selenium deficiency may increase risk of diseases of aging FASEB J. 25 2011 1793 1814
84. S. Wu, K. Sun, X. Wang, D. Wang, X. Wan, and J. Zhang Protonation of epigallocatechin-3-gallate (EGCG) results in massive aggregation and reduced oral bioavailability of EGCG-dispersed selenium nanoparticles J. Agric. Food Chem. 61 2013 7268 7275
85. K. Hirota, M. Murata, Y. Sachi, H. Nakamura, J. Takeuchi, K. Mori, and J. Yodoi Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB J. Biol. Chem. 274 1999 27891 27897
86. J.M. Heilman, T.J. Burke, C.J. McClain, and W.H. Watson Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase activity Free Radic. Biol. Med. 51 2011 1533 1542
87. K. Hirota, M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1 Proc. Natl. Acad. Sci. U. S. A. 94 1997 3633 3638 (Pubitemid 27180424)
88. A. Nishiyama, M. Matsui, S. Iwata, K. Hirota, H. Masutani, H. Nakamura, Y. Takagi, H. Sono, Y. Gon, and J. Yodoi Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression J. Biol. Chem. 274 1999 21645 21650
89. K. Yamada, C. Noguchi, K. Kamitori, Y. Dong, Y. Hirata, M.A. Hossain, I. Tsukamoto, M. Tokuda, and F. Yamaguchi Rare sugar d-allose strongly induces thioredoxin-interacting protein and inhibits osteoclast differentiation in Raw264 cells Nutr. Res. 32 2012 116 123
90. A. Sakurai, K. Yuasa, Y. Shoji, S. Himeno, M. Tsujimoto, M. Kunimoto, N. Imura, and S. Hara Overexpression of thioredoxin reductase 1 regulates NF-kappa B activation J. Cell. Physiol. 198 2004 22 30 (Pubitemid 38120962)
91. Y. Henrotin, F. Priem, and A. Mobasheri Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management Springerplus 2 2013 56
92. F. Hussan, N.G. Ibraheem, T.A. Kamarudin, A.N. Shuid, I.N. Soelaiman, and F. Othman Curcumin protects against ovariectomy-induced bone changes in rat model Evid. Based Complement. Alternat. Med. 2012 2012 174916
93. W. Cai, B. Zhang, D. Duan, J. Wu, and J. Fang Curcumin targeting the thioredoxin system elevates oxidative stress in HeLa cells Toxicol. Appl. Pharmacol. 262 2012 341 348
94. J. Fang, J. Lu, and A. Holmgren Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity J. Biol. Chem. 280 2005 25284 25290 (Pubitemid 40934623)
95. P. Javvadi, L. Hertan, R. Kosoff, T. Datta, J. Kolev, R. Mick, S.W. Tuttle, and C. Koumenis Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells Cancer Res. 70 2010 1941 1950
96. A.C. Bharti, Y. Takada, and B.B. Aggarwal Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis J. Immunol. 172 2004 5940 5947 (Pubitemid 38621193)
97. H.J. Moon, W.K. Ko, S.W. Han, D.S. Kim, Y.S. Hwang, H.K. Park, and I.K. Kwon Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation Biochem. Biophys. Res. Commun. 418 2012 247 253
98. W.K. Kim, K. Ke, O.J. Sul, H.J. Kim, S.H. Kim, M.H. Lee, H.J. Kim, S.Y. Kim, H.T. Chung, and H.S. Choi Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis J. Cell. Biochem. 112 2011 3159 3166
99. O.J. Sul, J.C. Kim, T.W. Kyung, H.J. Kim, Y.Y. Kim, S.H. Kim, J.S. Kim, and H.S. Choi Gold nanoparticles inhibited the receptor activator of nuclear factor-κb ligand (RANKL)-induced osteoclast formation by acting as an antioxidant Biosci. Biotechnol. Biochem. 74 2010 2209 2213
100. Y. Omata, M. Folan, M. Shaw, R.L. Messer, P.E. Lockwood, D. Hobbs, S. Bouillaguet, H. Sano, J.B. Lewis, and J.C. Wataha Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1) Toxicol. in Vitro 20 2006 882 890
101. L. Engman, M. McNaughton, M. Gajewska, S. Kumar, A. Birmingham, and G. Powis Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds Anticancer Drugs 17 2006 539 544 (Pubitemid 44321405)
102. A.D. Smith, C.A. Guidry, V.C. Morris, and O.A. Levander Aurothioglucose inhibits murine thioredoxin reductase activity in vivo J. Nutr. 129 1999 194 198 (Pubitemid 29044781)
103. S.E. Jackson-Rosario, and W.T. Self Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery Metallomics 2 2010 112 116
104. S.J. Vargas, T.G. Jones, M.M. Hurley, and L.G. Raisz Comparison of the effects of auranofin, gold sodium thiomalate, and penicillamine on resorption of cultured fetal rat long bones J. Bone Miner. Res. 2 1987 183 189
105. T.J. Hall, H. Jeker, H. Nyugen, and M. Schaeublin Gold salts inhibit osteoclastic bone resorption in vitro Inflamm. Res. 45 1996 230 233 (Pubitemid 26159994)
106. R.F. Burk, and K.E. Hill Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis Annu. Rev. Nutr. 25 2005 215 235 (Pubitemid 41209001)
107. R.F. Burk, and K.E. Hill Selenoprotein P. A selenium-rich extracellular glycoprotein J. Nutr. 124 1994 1891 1897 (Pubitemid 24334623)
108. K. Renko, M. Werner, I. Renner-Müller, T.G. Cooper, C.H. Yeung, B. Hollenbach, M. Scharpf, J. Köhrle, L. Schomburg, and U. Schweizer Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice Biochem. J. 409 2008 741 749 (Pubitemid 351214200)
109. K.E. Hill, J. Zhou, W.J. McMahan, A.K. Motley, J.F. Atkins, R.F. Gesteland, and R.F. Burk Deletion of selenoprotein P alters distribution of selenium in the mouse J. Biol. Chem. 278 2003 13640 13646 (Pubitemid 36799899)
110. L. Schomburg, U. Schweizer, B. Holtmann, L. Flohé, M. Sendtner, and J. Köhrle Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues Biochem. J. 370 2003 397 402 (Pubitemid 36315127)
111. R.F. Burk, and K.E. Hill Selenoprotein P-expression, functions, and roles in mammals Biochim. Biophys. Acta 1790 2009 1441 1447
112. M.B. Krol, J. Gromadzinska, and W. Wasowicz SeP, ApoER2 and megalin as necessary factors to maintain Se homeostasis in mammals J. Trace Elem. Med. Biol. 26 2012 262 266
113. R.F. Burk, K.E. Hill, G.E. Olson, E.J. Weeber, A.K. Motley, V.P. Winfrey, and L.M. Austin Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed J. Neurosci. 27 2007 6207 6211 (Pubitemid 46890009)
114. J. Chiu-Ugalde, F. Theilig, T. Behrends, J. Drebes, C. Sieland, P. Subbarayal, J. Köhrle, A. Hammes, L. Schomburg, and U. Schweizer Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain Biochem. J. 431 2010 103 111
115. G.E. Olson, V.P. Winfrey, K.E. Hill, and R.F. Burk Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells J. Biol. Chem. 283 2008 6854 6860
116. D. Behne, H. Hilmert, S. Scheid, H. Gessner, and W. Elger Evidence for specific selenium target tissues and new biologically important selenoproteins Biochim. Biophys. Acta 966 1988 12 21
117. M. Kühbacher, J. Bartel, B. Hoppe, D. Alber, G. Bukalis, A.U. Bräuer, D. Behne, and A. Kyriakopoulos The brain selenoproteome: priorities in the hierarchy and different levels of selenium homeostasis in the brain of selenium-deficient rats J. Neurochem. 110 2009 133 142
118. S.C. Schriever, K.M. Barnes, J.K. Evenson, A.M. Raines, and R.A. Sunde Selenium requirements are higher for glutathione peroxidase-1 mRNA than gpx1 activity in rat testis Exp. Biol. Med. 234 2009 513 521
119. N. Pietschmann, E. Rijntjes, A. Hoeg, and L. Schomburg On the importance of selenium for bone physiology Bone 51 2012 S15
120. A. Nakayama, K.E. Hill, L.M. Austin, A.K. Motley, and R.F. Burk All regions of mouse brain are dependent on selenoprotein P for maintenance of selenium J. Nutr. 137 2007 690 693 (Pubitemid 46397504)
121. A. Hög, K. Renko, P. Seemann, U. Kornak, and L. Schomburg Reduced selenoprotein P expression affects bone formation Endocr. Abstr. 20 2009 OC6 (6)
122. M.R. Bösl, K. Takaku, M. Oshima, S. Nishimura, and M.M. Taketo Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp) Proc. Natl. Acad. Sci. U. S. A. 94 1997 5531 5534 (Pubitemid 27241803)
123. E. Kumaraswamy, B.A. Carlson, F. Morgan, K. Miyoshi, G.W. Robinson, D. Su, S. Wang, E. Southon, L. Tessarollo, B.J. Lee, V.N. Gladyshev, L. Hennighausen, and D.L. Hatfield Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium Mol. Cell. Biol. 23 2003 1477 1488 (Pubitemid 36246031)
124. C.M. Downey, C.R. Horton, B.A. Carlson, T.E. Parsons, D.L. Hatfield, B. Hallgrímsson, and F.R. Jirik Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease PLoS Genet. 5 2009 e1000616
125. A. Wojcicka, J.H. Bassett, and G.R. Williams Mechanisms of action of thyroid hormones in the skeleton Biochim. Biophys. Acta 1830 2013 3979 3986
126. J. Köhrle, F. Jakob, B. Contempré, and J.E. Dumont Selenium, the thyroid, and the endocrine system Endocr. Rev. 26 2006 944 984 (Pubitemid 41770159)
127. A.M. Dumitrescu, X.H. Liao, M.S. Abdullah, J. Lado-Abeal, F.A. Majed, L.C. Moeller, G. Boran, L. Schomburg, R.E. Weiss, and S. Refetoff Mutations in SECISBP2 result in abnormal thyroid hormone metabolism Nat. Genet. 37 2005 1247 1252 (Pubitemid 41568708)
128. M.F. Azevedo, G.B. Barra, L.A. Naves, L.F. Ribeiro Velasco, P. Godoy Garcia Castro, L.C. de Castro, A.A. Amato, A. Miniard, D. Driscoll, L. Schomburg, and F. de Assis Rocha Neves Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene J. Clin. Endocrinol. Metab. 95 2010 4066 4071
129. C. Di Cosmo, N. McLellan, X.H. Liao, K.K. Khanna, R.E. Weiss, L. Papp, and S. Refetoff Clinical and molecular characterization of a novel selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X) J. Clin. Endocrinol. Metab. 94 2009 4003 4009
130. L. Schomburg, A.M. Dumitrescu, X.H. Liao, B. Bin-Abbas, J. Hoeflich, J. Köhrle, and S. Refetoff Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations Thyroid 19 2009 277 281
131. T. Hamajima, Y. Mushimoto, H. Kobayashi, Y. Saito, and K. Onigata Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation Eur. J. Endocrinol. 166 2012 757 764
132. J.J. Cao, B.R. Gregoire, and H. Zeng Selenium deficiency decreases antioxidative capacity and is detrimental to bone microarchitecture in mice J. Nutr. 142 2012 1526 1531
133. R. Moreno-Reyes, D. Egrise, J. Nève, J.L. Pasteels, and A. Schoutens Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia J. Bone Miner. Res. 16 2001 1556 1563 (Pubitemid 32675208)
134. F. Mathieu, F. Begaux, Z.Y. Lan, C. Suetens, and M. Hinsenkamp Clinical manifestations of Kashin-Beck disease in Nyemo Valley, Tibet Int. Orthop. 21 1997 151 156 (Pubitemid 27371114)
135. F. Mathieu, F. Begaux, C. Suetens, V. De Maertelaer, and M. Hinsenkamp Anthropometry and clinical features of Kashin-Beck disease in central Tibet Int. Orthop. 25 2001 138 141 (Pubitemid 32606137)
136. M. Hinsenkamp, F. Ryppens, F. Begaux, F. Mathieu, V. De Maertelaer, M. Lepeire, E. Haubruge, C. Chasseur, and B. Stallenberg The anatomical distribution of radiological abnormalities in Kashin-Beck disease in Tibet Int. Orthop. 25 2001 142 146 (Pubitemid 32606138)
137. G. Xiong Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China Int. Orthop. 25 2001 147 150 (Pubitemid 32606139)
138. Y. Jirong, P. Huiyun, Y. Zhongzhe, D. Birong, L. Weimin, Y. Ming, and S. Yi Sodium selenite for treatment of Kashin-Beck disease in children: a systematic review of randomised controlled trials Osteoarthr. Cartil. 20 2012 605 613
139. R. Moreno-Reyes, C. Suetens, F. Mathieu, F. Begaux, D. Zhu, M.T. Rivera, M. Boelaert, J. Nève, N. Perlmutter, and J. Vanderpas Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status N. Engl. J. Med. 339 1998 1112 1120 (Pubitemid 28465759)
140. R. Moreno-Reyes, F. Mathieu, M. Boelaert, F. Begaux, C. Suetens, M.T. Rivera, J. Nève, N. Perlmutter, and J. Vanderpas Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy Am. J. Clin. Nutr. 78 2003 137 144 (Pubitemid 39655259)
141. A.J. Duffield, C.D. Thomson, K.E. Hill, and S. Williams An estimation of selenium requirements for New Zealanders Am. J. Clin. Nutr. 70 1999 896 903 (Pubitemid 29512917)
142. Y. Xia, K.E. Hill, D.W. Byrne, J. Xu, and R.F. Burk Effectiveness of selenium supplements in a low-selenium area of China Am. J. Clin. Nutr. 81 2005 829 834 (Pubitemid 41724990)
143. M.P. Rayman The importance of selenium to human health Lancet 356 2000 233 241 (Pubitemid 30446984)
144. J. Nève Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity J. Trace Elem. Med. Biol. 9 1995 65 73
145. P. Kang, Y. Yao, J. Yang, B. Shen, Z. Zhou, and F. Pei An animal model of Kashin-Beck disease induced by a low-nutrition diet and exposure to T-2 toxin Osteoarthr. Cartil. 21 2013 1108 1115
146. Y.F. Yao, F.X. Pei, X.B. Li, J. Yang, B. Shen, Z.K. Zhou, L. Li, and P.D. Kang Preventive effects of supplemental selenium and selenium plus iodine on bone and cartilage development in rats fed with diet from Kashin-Beck disease endemic area Biol. Trace Elem. Res. 146 2012 199 206
147. Y. Yao, F. Pei, and P. Kang Selenium, iodine, and the relation with Kashin-Beck disease Nutrition 27 2011 1095 1100
148. L.G. Raisz Pathogenesis of osteoporosis: concepts, conflicts, and prospects J. Clin. Invest. 115 2005 3318 3325 (Pubitemid 43121814)
149. J. Lu, and A. Holmgren The thioredoxin antioxidant system Free Radic. Biol. Med. 66 2014 75 87
150. S.X. Tan, D. Greetham, S. Raeth, C.M. Grant, I.W. Dawes, and G.G. Perrone The thioredoxin-thioredoxin reductase system can function in vivo as an
151. S.M. Kanzok, A. Fechner, H. Bauer, J.K. Ulschmid, H.M. Müller, J. Botella-Munoz, S. Schneuwly, R. Schirmer, and K. Becker Substitution of the thioredoxin system for glutathione reductase in Drosophila melanogaster Science 291 2001 643 646 (Pubitemid 32150421)
152. Y. Wang, H. Lu, D. Wang, S. Li, K. Sun, X. Wan, E.W. Taylor, and J. Zhang Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase Toxicol. Appl. Pharmacol. 265 2012 342 350
153. J. Zhang, and H. Lu Ifosfamide induces acute renal failure via inhibition of the thioredoxin reductase activity Free Radic. Biol. Med. 43 2007 1574 1583 (Pubitemid 350122981)
154. M.A. Fath, I.M. Ahmad, C.J. Smith, J. Spence, and D.R. Spitz Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism Clin. Cancer Res. 17 2011 6206 6217
155. X. Wang, J. Zhang, and T. Xu Cyclophosphamide-evoked heart failure involves pronounced co-suppression of cytoplasmic thioredoxin reductase activity and non-protein free thiol level Eur. J. Heart Fail. 11 2009 154 162
156. J. Lu, E.H. Chew, and A. Holmgren Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide Proc. Natl. Acad. Sci. U. S. A. 104 2007 12288 12293 (Pubitemid 47206130)
157. J.M. Lean, J.T. Davies, K. Fuller, C.J. Jagger, B. Kirstein, G.A. Partington, Z.L. Urry, and T.J. Chambers A crucial role for thiol antioxidants in estrogen-deficiency bone loss J. Clin. Invest. 112 2003 915 923 (Pubitemid 38063749)
158. S. Muthusami, I. Ramachandran, B. Muthusamy, G. Vasudevan, V. Prabhu, V. Subramaniam, A. Jagadeesan, and S. Narasimha Ovariectomy induces oxidative stress and impairs bone antioxidant system in adult rats Clin. Chim. Acta 360 2005 81 86 (Pubitemid 41225396)
159. R. Ebert, and F. Jakob Selenium deficiency as a putative risk factor for osteoporosis Int. Congr. Ser. 1297 2007 158 164
160. A. Hoeg, A. Gogakos, E. Murphy, S. Mueller, J. Köhrle, D.M. Reid, C.C. Glüer, D. Felsenberg, C. Roux, R. Eastell, L. Schomburg, and G.R. Williams Bone turnover and bone mineral density are independently related to selenium status in healthy euthyroid postmenopausal women J. Clin. Endocrinol. Metab. 97 2012 4061 4070
161. M.R. Law, and A.K. Hackshaw A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect BMJ 315 1997 841 846 (Pubitemid 27420442)
162. J. Zhang, R.G. Munger, N.A. West, D.R. Cutler, H.J. Wengreen, and C.D. Corcoran Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status Am. J. Epidemiol. 163 2006 9 17 (Pubitemid 43007110)
163. P.P. Tak, and G.S. Firestein NF-kappaB: a key role in inflammatory diseases J. Clin. Invest. 107 2001 7 11 (Pubitemid 32047405)
164. A.V. Miagkov, D.V. Kovalenko, C.E. Brown, J.R. Didsbury, J.P. Cogswell, S.A. Stimpson, A.S. Baldwin, and S.S. Makarov NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint Proc. Natl. Acad. Sci. U. S. A. 95 1998 13859 13864 (Pubitemid 28523063)
165. Z. Han, D.L. Boyle, A.M. Manning, and G.S. Firestein AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis Autoimmunity 28 1998 197 208 (Pubitemid 29027651)
166. P.W. Tsao, T. Suzuki, R. Totsuka, T. Murata, T. Takagi, Y. Ohmachi, H. Fujimura, and I. Takata The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis Clin. Immunol. Immunopathol. 83 1997 173 178 (Pubitemid 27195937)
167. D.M. Gerlag, L. Ransone, P.P. Tak, Z. Han, M. Palanki, M.S. Barbosa, D. Boyle, A.M. Manning, and G.S. Firestein The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis J. Immunol. 165 2000 1652 1658 (Pubitemid 30604604)
168. T. Tomita, E. Takeuchi, N. Tomita, R. Morishita, M. Kaneko, K. Yamamoto, T. Nakase, H. Seki, K. Kato, Y. Kaneda, and T. Ochi Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy Arthritis Rheum. 42 1999 2532 2542 (Pubitemid 30327169)
169. R. Seetharaman, A.L. Mora, G. Nabozny, M. Boothby, and J. Chen Essential role of T cell NF-kappa B activation in collagen-induced arthritis J. Immunol. 163 1999 1577 1583 (Pubitemid 29352782)
170. H. Vunta, F. Davis, U.D. Palempalli, D. Bhat, R.J. Arner, J.T. Thompson, D.G. Peterson, C.C. Reddy, and K.S. Prabhu The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages J. Biol. Chem. 282 2007 17964 17973 (Pubitemid 47100228)
171. U.H. Gandhi, N. Kaushal, K.C. Ravindra, S. Hegde, S.M. Nelson, V. Narayan, H. Vunta, R.F. Paulson, and K.S. Prabhu Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma J. Biol. Chem. 286 2011 27471 27482
172. H. Ueno, H. Kajihara, H. Nakamura, J. Yodoi, and K. Nakamuro Contribution of thioredoxin reductase to T-cell mitogenesis and NF-kappaB DNA-binding promoted by selenite Antioxid. Redox Signal. 9 2007 115 121 (Pubitemid 44901877)
173. I.Y. Kim, and T.C. Stadtman Inhibition of NF-kappaB DNA binding and nitric oxide induction in human T cells and lung adenocarcinoma cells by selenite treatment Proc. Natl. Acad. Sci. U. S. A. 94 1997 12904 12907 (Pubitemid 27518449)
174. A.T. Vieira, K.D. Silveira, M.C. Arruda, C.T. Fagundes, J.L. Gonçalves, T.A. Silva, M.J. Neves, M.A. Menezes, J.R. Nicoli, M.M. Teixeira, and F.S. Martins Treatment with Selemax®, a selenium-enriched yeast, ameliorates experimental arthritis in rats and mice Br. J. Nutr. 108 2012 1829 1838
175. Y. Sakr, V.P. Maia, C. Santos, J. Stracke, M. Zeidan, O. Bayer, and K. Reinhart Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis Crit. Care 18 2014 R68
176. L. Schomburg Selenium in sepsis - substitution, supplementation or pro-oxidative bolus? Crit. Care 18 2014 444
177. M.M. Maurice, H. Nakamura, S. Gringhuis, T. Okamoto, S. Yoshida, F. Kullmann, S. Lechner, E.A. van der Voort, A. Leow, J. Versendaal, U. Muller-Ladner, J. Yodoi, P.P. Tak, F.C. Breedveld, and C.L. Verweij Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis Arthritis Rheum. 42 1999 2430 2439 (Pubitemid 30333424)
178. S. Yoshida, T. Katoh, T. Tetsuka, K. Uno, N. Matsui, and T. Okamoto Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts J. Immunol. 163 1999 351 358 (Pubitemid 29295860)
179. Y. Kabuyama, T. Kitamura, J. Yamaki, M.K. Homma, S. Kikuchi, and Y. Homma Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells Biochem. Biophys. Res. Commun. 367 2008 491 496
180. H. Lemarechal, P. Anract, J.L. Beaudeux, D. Bonnefont-Rousselot, O.G. Ekindjian, and D. Borderie Impairment of thioredoxin reductase activity by oxidative stress in human rheumatoid synoviocytes Free Radic. Res. 41 2007 688 698 (Pubitemid 46845590)
181. W.F. Kean, and I.R. Kean Clinical pharmacology of gold Inflammopharmacology 16 2008 112 125
182. A. Lipton, R. Uzzo, R.J. Amato, G.K. Ellis, B. Hakimian, G.D. Roodman, and M.R. Smith The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors J. Natl. Compr. Cancer Netw. 7 2009 S1 S29
183. Y.C. Chen, D.M. Sosnoski, and A.M. Mastro Breast cancer metastasis to the bone: mechanisms of bone loss Breast Cancer Res. 12 2010 215
184. Y.C. Chen, D.M. Sosnoski, U.H. Gandhi, L.J. Novinger, K.S. Prabhu, and A.M. Mastro Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer Carcinogenesis 30 2009 1941 1948
185. T. Standal, M. Borset, and A. Sundan Role of osteopontin in adhesion, migration, cell survival and bone remodeling Exp. Oncol. 26 2006 179 184
186. H. Ihara, D.T. Denhardt, K. Furuya, T. Yamashita, Y. Muguruma, K. Tsuji, K.A. Hruska, K. Higashio, S. Enomoto, A. Nifuji, S.R. Rittling, and M. Noda Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin J. Biol. Chem. 276 2001 13065 13071
187. H. Yoshitake, S.R. Rittling, D.T. Denhardt, and M. Noda Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption Proc. Natl. Acad. Sci. U. S. A. 96 1999 8156 8160 (Pubitemid 29328424)
188. T. Ishii, S. Ohshima, T. Ishida, T. Mima, Y. Tabunoki, H. Kobayashi, M. Maeda, T. Uede, L. Liaw, N. Kinoshita, I. Kawase, and Y. Saeki Osteopontin as a positive regulator in the osteoclastogenesis of arthritis Biochem. Biophys. Res. Commun. 316 2004 809 815 (Pubitemid 38368024)
189. K.A. Furger, R.K. Menon, A.B. Tuck, V.H. Bramwell, and A.F. Chambers The functional and clinical roles of osteopontin in cancer and metastasis Curr. Mol. Med. 1 2001 621 632 (Pubitemid 33772040)
190. T.G. Hullinger, R.S. Taichman, D.A. Linseman, and M.J. Somerman Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3-E1 cells J. Cell. Biochem. 78 2000 607 616 (Pubitemid 30620706)
191. H. Singhal, D.S. Bautista, K.S. Tonkin, F.P. O'Malley, A.B. Tuck, A.F. Chambers, and J.F. Harris Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival Clin. Cancer Res. 3 1997 605 611 (Pubitemid 27211840)
192. Y.J. Chen, J.L. Shen, C.Y. Wu, Y.T. Chang, C.M. Chen, and F.Y. Lee Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis J. Am. Acad. Dermatol. 60 2009 225 230
193. A.B. Serwin, W. Wasowicz, J. Gromadzinska, and B. Chodynicka Selenium status in psoriasis and its relations to the duration and severity of the disease Nutrition 19 2003 301 304 (Pubitemid 36390121)
194. D. Kadry, and L. Rashed Plasma and tissue osteopontin in relation to plasma selenium in patients with psoriasis J. Eur. Acad. Dermatol. Venereol. 26 2012 66 70
195. P.J. Marie Transcription factors controlling osteoblastogenesis Arch. Biochem. Biophys. 473 2008 98 105
196. H. Liu, Q. Lu, and K. Huang Selenium suppressed hydrogen peroxide-induced vascular smooth muscle cells calcification through inhibiting oxidative stress and ERK activation J. Cell. Biochem. 111 2010 1556 1564
197. E. Unni, F.S. Kittrell, U. Singh, and R. Sinha Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine Breast Cancer Res. 6 2004 R586 R592
198. P.H. Anborgh, J.C. Mutrie, A.B. Tuck, and A.F. Chambers Role of the metastasis-promoting protein osteopontin in the tumour microenvironment J. Cell. Mol. Med. 14 2010 2037 2044
199. N.I. Johnston, V.K. Gunasekharan, A. Ravindranath, C. O'Connell, P.G. Johnston, and M.K. El-Tanani Osteopontin as a target for cancer therapy Front. Biosci. 13 2008 4361 4372 (Pubitemid 351599688)
200. M.K. El-Tanani Role of osteopontin in cellular signaling and metastatic phenotype Front. Biosci. 13 2008 4276 4284 (Pubitemid 351599683)
201. Y.C. Chen, K.S. Prabhu, and A.M. Mastro Is selenium a potential treatment for cancer metastasis? Nutrients 5 2013 1149 1168
202. Y.C. Chen, K.S. Prabhu, A. Das, and A.M. Mastro Dietary selenium supplementation modifies breast tumor growth and metastasis Int. J. Cancer 133 2013 2054 2064
203. P. Hadji, M.S. Aapro, J.J. Body, N.J. Bundred, A. Brufsky, R.E. Coleman, M. Gnant, T. Guise, and A. Lipton Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment Ann. Oncol. 22 2011 2546 2555
204. P. Hadji, J.J. Body, M.S. Aapro, A. Brufsky, R.E. Coleman, T. Guise, A. Lipton, and M. Tubiana-Hulin Practical guidance for the management of aromatase inhibitor-associated bone loss Ann. Oncol. 19 2008 1407 1416
205. R. Rizzoli, J.J. Body, A. DeCensi, J.Y. Reginster, P. Piscitelli, M.L. Brandi, and European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO) Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper Osteoporos. Int. 23 2012 2567 2576
206. K.K. Vekariya, J. Kaur, and K. Tikoo Alleviating anastrozole induced bone toxicity by selenium nanoparticles in SD rats Toxicol. Appl. Pharmacol. 268 2013 212 220
207. N. Metes-Kosik, I. Luptak, P.M. Dibello, D.E. Handy, S.S. Tang, H. Zhi, F. Qin, D.W. Jacobsen, J. Loscalzo, and J. Joseph Both selenium deficiency and modest selenium supplementation lead to myocardial fibrosis in mice via effects on redox-methylation balance Mol. Nutr. Food Res. 56 2012 1812 1824
208. H. Steinbrenner, B. Speckmann, and H. Sies Toward understanding success and failures in the use of selenium for cancer prevention Antioxid. Redox Signal. 19 2013 181 191
209. M.P. Rayman Selenium and human health Lancet 379 2012 1256 1268